Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
about
Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer.NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function declinePolymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.Ultrasound-guided radiofrequency ablation enhances natural killer-mediated antitumor immunity against liver cancer.
P2860
Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Upregulated expression of NKG2 ...... ets for patients with thymoma.
@en
Upregulated expression of NKG2 ...... ets for patients with thymoma.
@nl
type
label
Upregulated expression of NKG2 ...... ets for patients with thymoma.
@en
Upregulated expression of NKG2 ...... ets for patients with thymoma.
@nl
prefLabel
Upregulated expression of NKG2 ...... ets for patients with thymoma.
@en
Upregulated expression of NKG2 ...... ets for patients with thymoma.
@nl
P2093
P2860
P356
P1433
P1476
Upregulated expression of NKG2 ...... ets for patients with thymoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2015.29
P577
2015-06-26T00:00:00Z